Intestinal candidiasis. A clinical report and comments about this opportunistic pathology
An eight-years-old girl, who presented with recurrent upper respiratory tract infections, was treated with broad-spectrum antibiotics. Afterward she presented with intestinal candidiasis. The isolated species was identified as Candida albicans by differential tests. Treatment given was with 500,000 IU of oral nystatin every 8 hours for 10 days and intestinal normal microbiota restoratives. Evolution has been satisfactory, although concomitantly type A hepatitis developed. Rest and a soft diet were recommended. The child is now perfectly healthy with normal liver function tests. Conclusion: Prolonged treatments with broad-spectrum antibiotics destroyed the indigenous intestinal microbiota, which provoked intestinal C. Albicans proliferation and adversely affected the immunological system of the patient, thus facilitating the establishment of a viral infection.
Unable to display preview. Download preview PDF.
- 1.Kennedy MJ, Volz PA. Ecology of Candida albicans gut colonization: Inhibition of Candida adhesion, colonization and dissemination from the gastrointestinal tract by bacterial antagonism. Infect Immunity 1985; 49: 654–663.Google Scholar
- 3.Colina AR, Aumont F, Deslauriers N, Bellmineur P, de Repentigny L. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect Immunity 1996; 64: 4514–4519.Google Scholar
- 6.Isenberg HD, Pisano MA, Carito SL, Berkman JI. Factors leading to overt monilial disease. Preliminary studies of the ecological relationship between Candida albicans and intestinal bacteria. Antibiot Chemother 1960; 6: 353–363.Google Scholar
- 9.Wals TJ, González C, Klyman CA, Chanock SJ, Pizzo PA. Invasive fungal infections in children: Recent advances in diagnosis and treatment. Adv Pediatr Infect Dis 1996; 11: 180–290.Google Scholar
- 10.Fisher-Hoch S, Huatwagner L. Opportunistic candidiasis: An epidemic of the 80's. Clin Inf Dis 1995; 21: 897–904.Google Scholar
- 12.Zimmerman LE. Fatal fungus infections complicating other diseases. Am J Clin Pthol 1995; 25: 46–65.Google Scholar
- 14.Wagner RD, Warner T, Pierson C, Roberts L, Farner J, Dohnalek M, Hilty M, Balish E. Variable biotherapeutic effects of Biffidobacterium spp. on orogastric and systemic candidiasis in immunodeficient mice. Rev Iberoam Micol 1998; 15: 265–270.Google Scholar
- 15.Wagner RD, Warner T, Roberts L, Farmer J, Dohnalek M, Hilty M, Balish E. Variable biotherapeutic effects of Lactobacillus acidophilus isolates on orogastric and systemic candidiasis in immunodeficient mice. Rev Iberoam Micol 1998; 15: 271–276.Google Scholar
- 16.Berg R, Bernasconi P, Fowler D, Gantreux M. Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Sacharomyces boulardii. J Inf Dis 1993; 168: 1314–1318.Google Scholar
- 18.Symposium LACTEOL 2000 Nuevas Perspectivas Fundamentales y Clínicas sobre el uso Terapéutico del liofilizado del termolizado de Lactobacillus acidophilus boucardii cepa L.B. en el tratamiento del Síndrome Diarreico. Rev Enf Pediatr 2001; Vol. XIV, NÚmero especial.Google Scholar